tiprankstipranks
Poolbeg Pharma Ltd. (GB:POLB)
:POLB

Poolbeg Pharma Ltd. (POLB) Price & Analysis

Compare
20 Followers

POLB Stock Chart & Stats


---

Financials

Quarterly

Options Prices

Currently, No data available
---

Ownership Overview

7.62%92.38%
7.62%
Insiders
― Other Institutional Investors
92.38% Public Companies and
Individual Investors

POLB FAQ

What was Poolbeg Pharma Ltd.’s price range in the past 12 months?
Poolbeg Pharma Ltd. lowest share price was 2.70p and its highest was 15.77p in the past 12 months.
    What is Poolbeg Pharma Ltd.’s market cap?
    Currently, no data Available
    When is Poolbeg Pharma Ltd.’s upcoming earnings report date?
    Poolbeg Pharma Ltd.’s upcoming earnings report date is Sep 09, 2025 which is in 180 days.
      How were Poolbeg Pharma Ltd.’s earnings last quarter?
      Currently, no data Available
      Is Poolbeg Pharma Ltd. overvalued?
      According to Wall Street analysts Poolbeg Pharma Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Poolbeg Pharma Ltd. pay dividends?
        Poolbeg Pharma Ltd. does not currently pay dividends.
        What is Poolbeg Pharma Ltd.’s EPS estimate?
        Poolbeg Pharma Ltd.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Poolbeg Pharma Ltd. have?
        Poolbeg Pharma Ltd. has 500,000,000 shares outstanding.
          What happened to Poolbeg Pharma Ltd.’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Poolbeg Pharma Ltd.?
          Currently, no hedge funds are holding shares in GB:POLB
          ---

          Company Description

          Poolbeg Pharma Ltd.

          Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables us to develop multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for Big Pharma seeking mid-stage products to license or acquire.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Scancell Holdings
          Synairgen
          Open Orphan Plc
          Oxford BioMedica
          Popular Stocks
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis